Versant Venture Capital VI, L.P. 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-08-09 7:06 pm Sale |
2024-08-07 | 13D | Passage Bio, Inc. PASG |
Versant Venture Capital VI, L.P. | 0 0.000% |
-4,026,417![]() (Position Closed) |
Filing |
2024-05-29 4:35 pm Unchanged |
2024-05-24 | 13D | Passage Bio, Inc. PASG |
Versant Venture Capital VI, L.P. | 4,026,417 6.500% |
0 (Unchanged) |
Filing |
2023-11-09 5:27 pm Unchanged |
2023-08-07 | 13D | Passage Bio, Inc. PASG |
Versant Venture Capital VI, L.P. | 4,026,417 7.300% |
0 (Unchanged) |
Filing |